Skip to main content

Table 4 Incidence rate of adverse reaction

From: A systematic review and meta-analysis on sodium tanshinone IIA sulfonate injection for the adjunctive therapy of pulmonary heart disease

Type

Number of adverse reactions

References

Treatment group

Control group

Nausea and vomiting

2

3

Chai et al., 2017.

Rhinobyon

1

3

Chai et al., 2017.

Orthostatic hypotension

1

2

Chai et al., 2017.

Tachycardia

0

2

Chai et al., 2017.

Dry cough

7

2

Liang, 2016; Liu et al., 2017; Lu et al., 2014; Mei 2018; Song et al., 2017.

Hypotension

5

1

Liang, 2016; Liu et al., 2017; Lu et al., 2014; Mei 2018; Song et al., 2017.

Abnormal liver function

1

2

Zhang et al., 2018.

Urticaria

2

2

Zhang et al., 2018.

Fever

1

2

Zhang et al., 2018.

Gastrointestinal reaction

1

1

Zhang et al., 2018.

Total event

21

20

 

Incidence rate

2.31% (21/909)

2.21% (20/906)

Â